Efficacy and Safety of Long-term Ketogenic Diet Therapy in a Patient With Type 1 Diabetes
Open Access
- 27 June 2024
- journal article
- case report
- Published by The Endocrine Society in JCEM Case Reports
- Vol. 2 (7) , luae102
Abstract
Fewer than 1% of patients with type 1 diabetes achieve normal glycemic control (glycated hemoglobin [HbA1c] < 5.7%/ < 39 mmol/mol). Additionally, exogenous insulin administration often causes “iatrogenic hyperinsulinemia,” leading to whole-body insulin resistance and increased risk of cardiovascular complications. We present data on the clinical efficacy and safety of a long-term (10-year) ketogenic diet (≤50 g carbohydrates/day) therapy in a patient with type 1 diabetes. The use of a ketogenic diet resulted in successful glycemic control, assessed by HbA1c (5.5%; 36.6 mmol/mol), continuous glucose monitoring median glucose (98 mg/dL; 5.4 mmol/L), and glucose time-in-range of 70 to 180 mg/dL (90%) without acute glycemic complications. In conjunction, there was a 43% decrease in daily insulin requirements. Low-density lipoprotein cholesterol increased, whereas small-dense low-density lipoprotein was in the normal range (<90 nmol/L). No adverse effects were observed on thyroid function, kidney function, or bone mineral density. This case report demonstrates that a long-term ketogenic diet in a person with type 1 diabetes has considerable therapeutic benefits.Keywords
Funding Information
- NIH (K01HL160772, K01HL147998, P30DK56341, UL1TR002345)
- American Heart Association (23CDA1037938)
This publication has 26 references indexed in Scilit:
- Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractilityBasic Research in Cardiology, 2023
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statementThe Lancet Diabetes & Endocrinology, 2022
- Metabolic and Signaling Roles of Ketone Bodies in Health and DiseaseAnnual Review of Nutrition, 2021
- Effects of modified Atkins diet on thyroid function in adult patients with pharmacoresistant epilepsyEpilepsy & Behavior, 2020
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018Diabetes Technology & Therapeutics, 2019
- The ups and downs of low‐carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomesDiabetic Medicine, 2018
- Hypoglycemia, Diabetes, and Cardiovascular DiseaseDiabetes Technology & Therapeutics, 2012
- Vascular disease and diabetes: is hypoglycaemia an aggravating factor?Diabetes/Metabolism Research and Reviews, 2008
- Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemiaThe American Journal of Clinical Nutrition, 2006
- Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetesDiabetologia, 2003